The Clinical Evaluation of Continuous Assistance Offered to Older People Living Independently.

NCT ID: NCT01218373

Last Updated: 2017-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2010 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-12-01

Study Completion Date

2013-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The clinical evaluation of the HOMESWEETHOME project sets out to assess the long-term effects of continuous assistance offered by the HOMESWEETHOME services to older people living independently. The trial will test the hypothesis that while providing a level of safety equivalent to or better than that enjoyed in older people"s homes, there is a significant positive effect on the quality of life (QoL) and the duration of independently living of older people.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The HOMESWEETHOME clinical trial is conducted as a multi-centre randomised control trial (RCT), across four pilot sites. The trial design, analysis and reporting follow the "Revised CONSORT - Consolidated Standards of Reporting Trials - Statement" and subsequent additions to the CONSORT statement.

HOMESWEETHOME services are expected to result in an outcome that is superior to usual care alone in reducing deterioration of health related quality of life and function associated with age and chronic disease. This effect will be measured by assessing different outcomes.

The clinical evaluation of the HOMESWEETHOME project sets out to assess the long-term effects of continuous assistance offered by the HOMESWEETHOME services to older people living independently. The trial will test the hypothesis that while providing a level of safety equivalent to or better than that enjoyed in older people"s homes, there is a significant positive effect on the quality of life (QoL) and the duration of independently living of older people.

The study is conducted in four sites within the European Union, these sites will have the number of participants randomised into Intervention Group and Control Group, as follows:

* Belgium - City of Antwerp 30 + 30
* Catalonia - Town of Badalona 15 + 15
* Ireland - North Eastern Region 30 + 30
* Italy - Town of Latina 30 + 30 The main inclusion criteria for participants" entry into the trial will be based on frailty. Frailty is a concept associated with adverse outcomes such as higher morbidity, more hospitalisations and falls, and a lower quality of life. Furthermore, frailty predicts - better than age - the evolution to disability and death. Participants must also be 65 years or over, and living at home. The main reasons for excluding participants will be based on their physical or mental (in)ability to take part.

The primary clinical outcome for the trials will be measured based on the Health Status Questionnaire Short Form 36 (SF-36) (v2).

Secondary outcomes will be measured using Edmonton Frailty Scale (EFS), Comprehensive Geriatric Assessment (CGA), Clinical Global Impression (CGI), and Hospital Anxiety and Depression Scale (HADS). A number of medical events will also be measured.

Measurements will be taken at trial start, trial mid-term, and trial end. Measurements will be entered, anonymously, into a database for analysis of results. The trial population size has been subjected to a statistical power analysis, to ensure statistical significance of project results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frailty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group: HOMESWEETHOME services

Monitoring and alarm handling services. eInclusion services. Domotica services. Daily scheduler. Navigation services. Cognitive training services. Non-technology based services.

Group Type ACTIVE_COMPARATOR

HOMESWEETHOME Services

Intervention Type DEVICE

Monitoring and alarm handling services. eInclusion services. Domotic services. Daily scheduler. Navigation services. Cognitive training services. Non-technology based services.

Control Group: No HOMESWEETHOME services

Normal care.

Group Type PLACEBO_COMPARATOR

No HOMESWEETHOME services installed

Intervention Type DEVICE

Normal care and healthcare without HOMESWEETHOME services.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HOMESWEETHOME Services

Monitoring and alarm handling services. eInclusion services. Domotic services. Daily scheduler. Navigation services. Cognitive training services. Non-technology based services.

Intervention Type DEVICE

No HOMESWEETHOME services installed

Normal care and healthcare without HOMESWEETHOME services.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

e.g. DREAMING project devices. no applicable

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 65 years or over.
* Living at home or in the community, i.e. not in a nursing home, acute or sub-acute clinical or care setting.
* Scoring "mildly frail" or "moderately frail" in Edmonton Frail Scale (EFS).

Exclusion Criteria

* Not willing to participate (e.g. no signing informed consent form).
* Living situation not suitable for independent living (also including long planned durations of absence from home).
* Physically, mentally or otherwise unable to use and / or operate HOMESWEETHOME devices / instruments.
* Unable to administer self-assessment measurements (e.g. monitoring vital signs; questionnaires).
* Significant impairment of language comprehension or expression (e.g. aphasia).
* Active medical illness with a significant shortened life expectancy (\< 6 months), based on mortality prognosis2.
* Living without access to ISDN or ADSL service.
* Living with another HOMESWEETHOME participant in the same home.
* Completely dependent on others for the activities of daily living.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ziekenhuis Netwerk Antwerpen (ZNA)

OTHER

Sponsor Role collaborator

EuroCross

UNKNOWN

Sponsor Role collaborator

Badalona Serveis Assistencials

OTHER

Sponsor Role collaborator

Department of Health, Generalitat de Catalunya

OTHER_GOV

Sponsor Role collaborator

Louth County Council

UNKNOWN

Sponsor Role collaborator

Health Services Executive North Eastern Area

UNKNOWN

Sponsor Role collaborator

TeleMedicina Rizzoli

UNKNOWN

Sponsor Role collaborator

Darco Servizi

UNKNOWN

Sponsor Role collaborator

Azienda USL di Latina

UNKNOWN

Sponsor Role collaborator

University of Roma La Sapienza

OTHER

Sponsor Role collaborator

Him SA

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wouter A Keijser, MD

Role: STUDY_DIRECTOR

Him SA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ZNA

Antwerp, Flanders, Belgium

Site Status

Netwell Centre

Dublin, , Ireland

Site Status

Viale P.L. Nervi, Centro Commerciale Latinafiori, Torre Girasoli, 4100 Latina

Latina, Lazio Regon, Italy

Site Status

Badalona Serveis Assistencials

Badalona, Catalonia, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Ireland Italy Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

250449

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

HSH-CLTRPR-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.